13F Holdings
中文EN

Casdin Capital, LLC

New York NY · SEC CIK 0001534261

2026Q22026Q1 9 earlier quarters 🔒
$2.00B2026Q2 reported value
43Positions
77.4%Top 10 weight · largest 24.2%
4 / 3New / sold out
Reported value over time$2.00B2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

RVMD 24.2%
RLAY 15.0%
WGS 12.7%
BIOLIFE SOLUTI 6.6%
ILMN 4.7%
LAB 3.7%
GPCR 3.2%
DNLI 2.6%
NGNE 2.4%
BEAM 2.3%

2026Q2 top buys estimated at quarter-end value

WGS Added+$48.06M
RLAY Added+$30.25M
SION New+$17.60M
SRRK Added+$17.32M
GRAL Added+$17.07M

2026Q2 top sells estimated at quarter-end value

TXG Reduced-$46.97M
BIOLIFE SOLUTION Reduced-$36.77M
GH Reduced-$19.50M
QGEN Sold out-$14.41M
TEM Sold out-$13.30M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
RVMD REVOLUTION MEDICINES INC $482.68M24.16%2,577,333 00.0% — Unchanged
RLAY RELAY THERAPEUTICS INC $300.02M15.02%16,035,240 1,616,66611.2% $30.25M Added
WGS GENEDX HOLDINGS CORP $254.50M12.74%3,707,164 700,00023.3% $48.06M Added
— BIOLIFE SOLUTIONS INC $131.46M6.58%4,655,000 -1,302,165-21.9% -$36.77M Reduced
ILMN ILLUMINA INC $93.19M4.66%530,000 00.0% — Unchanged
LAB STANDARD BIOTOOLS INC $73.04M3.66%88,783,856 00.0% — Unchanged
GPCR STRUCTURE THERAPEUTICS INC $63.06M3.16%1,175,000 00.0% — Unchanged
DNLI DENALI THERAPEUTICS INC $52.60M2.63%2,045,000 205,00011.1% $5.27M Added
NGNE NEUROGENE INC $48.60M2.43%1,545,361 125,0008.8% $3.93M Added
BEAM BEAM THERAPEUTICS INC $46.33M2.32%1,350,000 00.0% — Unchanged
TXG 10X GENOMICS INC $40.26M2.02%1,050,000 -1,225,000-53.8% -$46.97M Reduced
SRRK SCHOLAR ROCK HLDG CORP $36.58M1.83%665,000 315,00090.0% $17.32M Added
PSNL PERSONALIS INC $34.17M1.71%2,550,000 950,00059.4% $12.73M Added
GRAL GRAIL INC $32.77M1.64%480,000 250,000108.7% $17.07M Added
GH GUARDANT HEALTH INC $27.76M1.39%185,000 -130,000-41.3% -$19.50M Reduced
MAZE MAZE THERAPEUTICS INC $25.18M1.26%843,857 85,00011.2% $2.54M Added
HIMS HIMS & HERS HEALTH INC $24.27M1.21%700,000 00.0% — Unchanged
ALNY ALNYLAM PHARMACEUTICALS INC $22.58M1.13%75,000 00.0% — Unchanged
TSHA TAYSHA GENE THERAPIES INC $22.13M1.11%3,250,000 00.0% — Unchanged
AGMB AGOMAB THERAPEUTICS NV $20.12M1.01%1,550,000 00.0% — Unchanged
SEPN SEPTERNA INC $18.53M0.93%553,268 00.0% — Unchanged
PBLS PARABILIS MEDICINES INC $17.67M0.88%645,690 645,690— — First reported
SION SIONNA THERAPEUTICS INC $17.60M0.88%400,000 400,000— $17.60M New
VCYT VERACYTE INC $16.23M0.81%276,308 00.0% — Unchanged
ANL ADLAI NORTYE LTD $14.38M0.72%1,250,000 711,539132.1% $8.18M Added
PRME PRIME MEDICINE INC $11.69M0.58%3,167,175 00.0% — Unchanged
ABSI ABSCI CORPORATION $11.28M0.56%973,260 00.0% — Unchanged
DGX QUEST DIAGNOSTICS INC $10.60M0.53%50,000 00.0% — Unchanged
SRPT SAREPTA THERAPEUTICS INC $8.45M0.42%470,000 470,000— $8.45M New
QURE UNIQURE NV $6.91M0.35%150,000 150,000— $6.91M New
NTLA INTELLIA THERAPEUTICS INC $6.01M0.30%355,000 00.0% — Unchanged
MRNA MODERNA INC $5.25M0.26%75,000 00.0% — Unchanged
IRON DISC MEDICINE INC $4.75M0.24%65,000 00.0% — Unchanged
GLUE MONTE ROSA THERAPEUTICS INC $4.50M0.23%186,014 00.0% — Unchanged
IPSC CENTURY THERAPEUTICS INC $3.01M0.15%1,228,190 00.0% — Unchanged
CTNM CONTINEUM THERAPEUTICS INC $2.43M0.12%148,333 00.0% — Unchanged
BBOT BRIDGEBIO ONCOLOGY THERAPEUT $2.15M0.11%282,312 00.0% — Unchanged
EDIT EDITAS MEDICINE INC $1.44M0.07%445,000 445,000— $1.44M New
PACB PACIFIC BIOSCIENCES CALIF IN $1.22M0.06%723,767 00.0% — Unchanged
KARD KARDIGAN INC $1.19M0.06%50,000 50,000— — First reported
RXRX RECURSION PHARMACEUTICALS IN $606,7350.03%165,323 00.0% — Unchanged
DNA GINKGO BIOWORKS HOLDINGS INC $361,6460.02%36,493 00.0% — Unchanged
— TENAYA THERAPEUTICS INC $267,5310.01%361,969 00.0% — Unchanged
QGEN QIAGEN NV $00.00%0 -360,000-100.0% -$14.41M Sold out
TEM TEMPUS AI INC $00.00%0 -294,127-100.0% -$13.30M Sold out
MLTX MOONLAKE IMMUNOTHERAPEUTICS $00.00%0 -450,000-100.0% -$8.39M Sold out